Patient Rating:

4.8 out of 5

83 Patient Ratings
40 Patient Comments

Randy L. Jensen, M.D., Ph.D.

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 585-6065 Clinical Neurosciences Center
175 North Medical Drive East
Salt Lake City, UT 84132
Map
(801) 585-0260 Huntsman Cancer Institute
Patient Care Center
2000 Circle of Hope
Salt Lake City, UT 84112
Map

Bio

Randy L. Jensen, MD, PhD is a neurosurgeon with a practice focused on the treatment of patients with brain tumors. He has a particular emphasis using preoperative imaging, intraoperative navigation, intraoperative cortical mapping and intraoperative MRI to maximize tumor resection and minimize surgical complications. He treats patients with malignant, benign, and metastatic brain tumors. He has many clinical trials for patients with brain tumors and has a laboratory effort examining brain tumor biology. He is also a member of the Brain Tumor Research Team at Huntsman Cancer Institute.

Board Certification and Academic Information

Academic Departments Neurosurgery - Professor
Oncological Sciences - Adjunct Professor
Radiation Oncology - Adjunct Professor
Academic Divisions Adult Neurosurgery
Board Certification American Board of Neurological Surgery (Neurosurg)
Cancer Center Programs Experimental Therapeutics

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
4.9
My confidence in care provider
4.9
Time care provider spent with me
4.6
Care provider spoke using clear language
4.8
Care provider's effort to include me in decisions
4.8
Care provider's concern for questions & worries
4.8
Care provider's explanation of condition/problem
4.7
Wait time at clinic
4.2
Care provider's friendliness and courtesy
4.9

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

July 24, 2014

We understand that there are often "wait" periods....however, we know that when it is our turn the same unrushed time will be given us to be sure we leave the visit with questions answered and assured that someone "is in our corner!"

July 19, 2014

we learned a lot that we didn't learn elsewhwere. we were very impressed by how knowledgeable the doctors and the physicians assistant were. Yet they took time with us and treated us like we were important. This was a wonderful experience.

July 15, 2014

As good of an experience as a person can have going through this.

July 13, 2014

Dr. Jensen is great, he is very attentive to what my concerns are and answers all my questions.

July 07, 2014

Everything was great, but I feel that more emphasis on the impact of the surgery would have helped.

June 13, 2014

Dr. Jensen was friendly and down-to-earth in this approach and willing to let me make decisions on my care.

May 19, 2014

We were/are extremely pleased with our experience. When a family is in such a situation having health care persons who care, who listen, who are helpful is critical, Dr Jensen and his staff provided that comfort to us. Having traveled a distance and not knowing anyone, this eased our minds greatly.

April 28, 2014

Dr was great. Answered all my questions and I do not need any medications. I left feeling very good about my visit.

April 05, 2014

I really like Dr.Jensen

March 21, 2014

I love Dr Jensen and will always see him for my tumor

March 16, 2014

Dr Jensen is very personable and makes my husband and I feel like I am his only patient!

February 15, 2014

Dr. Randy Jensen is so wonderful.He is so kind,thoughtful,and patient.I absolutely feel like he saved my life and I truly trust him with my medical care.

February 14, 2014

Always a good experience with Dr. Jensen

February 02, 2014

Dr Randy Jensen was excellent as were the other members of team that I dealt with during my visit

January 25, 2014

We really like Dr Randy Jensen. Besides being very knowledgeable, he is so friendly and caring.

January 06, 2014

Given the reason we were there our experience could not have been a better one based on the helpfulness of all the caregivers that we dealt with

January 02, 2014

Loved the doctor (neurosurgeon)

December 21, 2013

Dr, Jensen seems to remember me even though I come every two years.

November 08, 2013

We love Dr Jensen. He is very understanding and takes all the time we need to understand. He explains things so we understand them. He is understanding and sensitive to the stress of our situation.

September 23, 2013

Wonderful and caring treatment and attention to detail. Great confidence booster.

September 09, 2013

The were great.

August 12, 2013

He was very personable and friendly.

August 02, 2013

I actually have referred a friend to dr Jensen and they also loved him!

July 04, 2013

There were many positive connections that we could use to support confidence.

June 19, 2013

Dr. Jensen is one of the kindest, most professional, knowledgeable, caring, comforting, and downright pleasant physicians with whom I have ever interacted. He is an excellent physician technically and delightful personally.

June 10, 2013

Dr. Jensen is a jedi master. Total confidence in him

June 03, 2013

The doctor was caring and personable.

June 03, 2013

Love Dr Jensen. So friendly and engaging. Knowledgeable. Caring.

February 25, 2013

Dr. Randy Jensen is always so kind and caring to me and my situation. I have nothing but wonderful things to write about him and his staff. I feel like he actually saved my life. Because of him and his expertise in the neurological field , he has changed my life and my health. My family and I am so grateful to him for this gift.

February 18, 2013

I appreciate Dr. Jensen always being so forthright with me.

December 17, 2012

They all seemed very helpful and concerned.

December 09, 2012

Dr. Jensen has been very helpful in addressing my concerns about ongoing migraines. His considerate attitude is exceptional.

October 03, 2012

Doctor Jensen treated our son with kindness and answered all of his questions as well as ours, and we had a lot of them (questions). He has the best bedside manner and such a comforting smile, we feel very fortunate to have him as our son surgeon.

September 10, 2012

Thank you to all who are involved

September 03, 2012

Incredible. Dr. Jensen is not only extremely knowledgeable, but friendly and funny - what a wonderful combination:-)

August 13, 2012

Randy is the best he makes sure I understand what is going on and is very quick to reply to phone calls, emails, and makes me feel like a person not just a client with a specific number

August 07, 2012

My wife and I love Dr. Jensen. From the start after first learning about my wife's brain tumor we felt the utmost confidence in his abilities and he has been very compassionate and caring throughout the diagnosis, surgery and follow up. In our last visit I wish we could have spent a little more time with him as it was really short and we left kind of feeling like "that's it?" This has been a life altering experience for us and we worry and wonder a lot about the future and would have liked to have had a little more time with him but I understand that he is very busy and I think that the outcome of my wife's surgery has been so good in his eyes that maybe he felt like she was doing so good that there wasn't much else to tell us. Regardless, he is a very good man and we feel fortunate to have had him as our neurosurgeon.

July 29, 2012

Dr Jensen was very thorough and gave me every option I could choose for treatment without forcing me in any way.

March 22, 2012

All elements in this group of questions were very good, and these are the most important questions.

February 10, 2012

They underestimated the time to get the pathology report which kept us on pins and needles for a few extra days, so would have preferred to have it more accurate, but this was a small thing overall

Academic Profile

Research Interests

  • Hypoxia Inducible Factor-1
  • IL-13 receptors
  • Hypoxia, Brain
  • Calcium Channel Antagonists
  • Gliasite
  • Stereotactic radiosurgery versus surgery for single brain metastasis
  • Diphtheria toxin-conjugated monoclonal antibody
  • Phase II 131-I
  • Cox-2

Board Certification and Academic Information

Academic Departments Neurosurgery - Professor
Oncological Sciences - Adjunct Professor
Radiation Oncology - Adjunct Professor
Academic Divisions Adult Neurosurgery
Board Certification American Board of Neurological Surgery (Neurosurg)
Cancer Center Programs Experimental Therapeutics

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 581-6908 School of Medicine
Neurosurgery
30 N Medical Dr
Salt Lake City, UT 84132

Academic Bio

Dr Randy Jensen is a neurosurgeon with a clinical practice focused on treating patients with brain tumors. He has extensive experience utilizing novel surgical methods to maximize tumor removal and minimize surgical complications. He is an expert on the use of preoperative planning and imaging to remove tumors from eloquent areas of the brain. He routinely performs awake craniotomy with intraoperative cortical mapping to avoid motor or speech injury during removal of tumors near these areas of the brain. He has instituted an intraoperative MRI program, the only one available in the Intermountain West. He also co-directs the Stereotactic Radiosurgery program which utilizes the Brain Lab Novalis Frameless Shaped Beam System for precise delivery of radiation for treatment of benign and malignant brain tumors. He and Dr Dennis Shrieve have treated over 1000 patients using these techniques.

Dr Jensen is Professor of Neurosurgery, Radiation Oncology and Oncological Sciences. He is a member of both the Experimental Therapeutics and the Nuclear Control of Cell Growth and Differentiation programs. He has served at a national level for various Neurosurgical Societies and was recently President of the Rocky Mountain Neurosurgery Society. He is the Associate Program Director for the Neurosurgery Residency program and Clerkship Director for medical students rotating on the Neurosurgery Service.

He is a Cancer Research Investigator at the Huntsman Cancer Institute and has a laboratory focused on animal models of meningioma and radiation necrosis. His laboratory studies brain tumor hypoxia and angiogenesis. He is the author of over 100 papers most on topics of brain tumor biology and patient outcome after brain tumor treatment.

He has been the principal investigator of many brain tumor clinical trials and continues to offer cutting edge treatments for patients with brain tumors.

Education

Education History

Type School Degree
Doctoral Training Loyola University Medical Center
Ph.D.
Residency Loyola University of Chicago
Neurosurgery
Resident
Professional Medical University of Utah Hospital School of Medicine
Medicine
M.D.
Undergraduate University of Utah
Biology
B.S.
Undergraduate University of Utah
Chemistry
B.A.

Publications

Selected Provider Publications

Journal Article

  1. Jensen RL, Mumert ML, Gillespie DL, Kinney AY, Schabel MC, Salzman KL (2014). Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome. Neuro Oncol, 16(2), 280-91.
  2. Towner RA, Jensen RL, Colman H, Vaillant B, Smith N, Casteel R, Saunders D, Gillespie DL, Silasi-Mansat R, Lupu F, Giles CB, Wren JD (2013). ELTD1, a Potential New Biomarker for Gliomas. Neurosurgery, 72(1), 77-91.
  3. Towner RA, Gillespie DL, Schwager A, Saunders DG, Smith N, Njoku CE, Krysiak RS 3rd, Larabee C, Iqbal H, Floyd RA, Bourne DW, Abdullah O, Hsu EW, Jensen RL (2013). Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007. Neuro Oncol, 15(3), 330-40.
  4. Chagovetz AA, Quinn C, Damarse N, Hansen LD, Chagovetz AM, Jensen RL (2013). Differential scanning calorimetry of gliomas: a new tool in brain cancer diagnostics? Neurosurgery, 73(2), 289-95.
  5. Tran DK, Jensen RL (2013). Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities. Surg Neurol Int, 4(Suppl 3), S129-35.
  6. Cohen AL, Salzman K, Palmer C, Jensen R, Colman H (2013). Bevacizumab is Effective for Recurrent Papillary Tumor of the Pineal Region: First Report. Case Rep Oncol, 6(2), 434-40.
  7. Towner RA, Jensen RL, Vaillant B, Colman H, Saunders D, Giles CB, Wren JD (2013). Experimental validation of 5 in-silico predicted glioma biomarkers. Neuro Oncol, 15(12), 1625-34.
  8. Doblas S, He T, Saunders D, Hoyle J, Smith N, Pye Q, Lerner M, Jensen RL, Towner RA (2012). In vivo characterization of several rodent glioma models by 1H MRS. NMR Biomed, 25(4), 685-94.
  9. Garber ST, Jensen RL (2012). Image guidance for brain metastases resection. Surg Neurol Int, 3(Suppl 2), S111-7.
  10. Enslow MS, Zollinger LV, Morton KA, Butterfield RI, Kadrmas DJ, Christian PE, Boucher KM, Heilbrun ME, Jensen RL, Hoffman JM (2012). Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma. Clin Nucl Med, 37(9), 854-61.
  11. Grossmann KF, Colman H, Akerley WA, Glantz M, Matsuoko Y, Beelen AP, Yu M, De Groot JF, Aiken RD, Olsen JJ, Evans BA, Jensen RL (2012). Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme. J Neurooncol, 110(2), 257-64.
  12. Abraham S, Hu N, Jensen RL (2012). Hypoxia-inducible factor-1–regulated protein expression and oligodendroglioma patient outcome: Comparison with preoperative UCSF low-grade scoring system. J Neurooncol, 108(3), 459-468.
  13. Lee J, Jensen RL (2012). Predicting Outcomes of Patients with Intracranial Meningiomas Using Molecular Markers of Hypoxia, Vascularity, and Proliferation. Neurosurgery, 71(1), 146-156.
  14. Jensen RL, Minshew L, Shrieve AF, Hu N, Shrieve DC (2012). Stereotactic radiosurgery and radiotherapy for meningiomas: biomarker predictors of patient outcome and response to therapy. Journal of Radiosurgery & SBRT, 2(1), 41-50.
  15. Prados M, Cloughesy T, Samant M, Fang L, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Das A, Friedman HS (2011). Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol, 13(1), 143-51.
  16. Wefel JS, Cloughesy T, Zazzali JL, Zheng M, Prados M, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Das A, Friedman HS (2011). Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol, 13(6), 660-8.
  17. Chagovetz AA, Jensen RL, Recht L, Glantz M, Chagovetz AM (2011). Preliminary use of differential scanning calorimetry of cerebrospinal fluid for the diagnosis of glioblastoma multiforme. J Neurooncol, 105(3), 499-506.
  18. Lin N, Dunn IF, Glantz M, Allison DL, Jensen R, Johnson MD, Friedlander RM, Kesari S (2011). Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study. J Neurosurg, 115(4), 730-6.
  19. Taussky P, Kalra R, Coppens J, Mohebali J, Jensen RL, Couldwell WT (2011). Endocrinological Outcome after Pituitary Transposition (Hypophysopexy) and Adjuvant Radiotherapy for Tumors Involving the Cavernous Sinus. J Neurosurg, 115(1), 55-62.
  20. Chintala S, Toth K, Cao S, Durrani FA, Vaughan MM, Jensen RL, Rustum YM (2010). Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha. Cancer Chemother Pharmacol, 66(5), 899-911.
  21. Jensen RL, Jensen PR, Shrieve AF, Hazard L, Shrieve DC (2010). Overall and progression-free survival and visual and endocrine outcomes for patients with parasellar lesions treated with intensity-modulated stereotactic radiosurgery. J Neurooncol, 98(2), 221-31.
  22. Vredenburgh JJ, Cloughesy T, Samant M, Prados M, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Das A, Friedman HS (2010). Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. Oncologist, 15(12), 1329-34.
  23. Schabel MC, DiBella EVR, Jensen RL, and Salzman KL (2010). A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: II In Vivo results. Phys Med Biol, 55, 4807-4823.
  24. Jensen RL, Shan JS, Freimark BD, Harris DA, King SW, Parseghian MH (2010). Clinical update: Treatment of glioblastoma multiforme with radiolabeled antibodies that target tumor necrosis. Current Cancer Therapy Reviews, 6(1), 13-18.
  25. Yu J, Blair S, Gillepsie D, Jensen R, Myszka D, Badran AH, Ghosh I, and Chagovetz A (2010). Direct DNA methylation profiling using methyl binding domain proteins. PMID 20507169. Anal Chem, 82, 5012-5019.
  26. Anker CJ, Hymas RV, Hazard LJ, Jensen RL, Shrieve D (2010). Effect of treatment volumes on patterns of failure in glioblastoma multiforme. In preparation. J Neurooncol.
  27. Prados M, Cloughesy T, Samant M, Fang L, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WKA, Paleologos N, Nicholas MK, Jensen RL, Vredenburgh J, Das A, and Friedman HS (2010). Evaluation of objective response as a predictor of survival in bevacizumab-treated patients with glioblastoma at first or second relapse in the BRAIN Study Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. Submitted to JCO. J Clin Oncol, 17.
  28. Jensen RL, Shrieve A, Jensen P, Shrieve D (2010). Intensity Modulated Radiosurgery for Parasellar Lesions: Technique and Long-term Outcomes. J Neurooncol.
  29. Smock K, She R, Jensen R, Crim J, Layfield L, and Chin S (2010). Malignant solitary fibrous tumor of the sciatic nerve: a case report and review of the literature. Submitted to the Am J of Surg Path. Am J Surg Pathol.
  30. Mumert, M, Jensen EM, Jensen RL (2010). Parafalcine lesions in the cancer patient:diagnostic dilemma meningioma or metastatic lesion. J Neurooncol, 99(1), 135-139.
  31. Sampson JH, Archer G, Pedain C, Wembacher-Schrder E, Westphal M, Kunwar S, Vogelbaum MA, Coan A, Herndon JE, Raghavan R, Brady ML, Reardon DA, Friedman AH, Friedman HS, Rodrguez-Ponce MI, Chang SM, Mittermeyer S, Croteau D, Puri RK, PRECISE Trial Investigators (2010). Poor drug distribution as a possible explanation for the results of the PRECISE trial. J Neurosurg, 113(2), 301-9.
  32. Anker CJ, Hymas RV, Hazard LJ, Boucher KM, Jensen RL, Shrieve DC (2010). Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme. J Neurooncol, 98(2), 253-263.
  33. Niazi TN, Jensen EM, Jensen RL (2009). WHO Grade II and III supratentorial hemispheric ependymomas in adults: case series and review of treatment options. J Neurooncol, 91(3), 323-8.
  34. Chang EF, Clark A, Jensen RL, Bernstein M, Guha A, Carrabba G, Mukhopadhyay D, Kim W, Liau LM, Chang SM, Smith JS, Berger MS, McDermott MW (2009). Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. J Neurosurg, 111(2), 203-10.
  35. Wang XL, Xu R, Wu X, Gillespie D, Jensen R, Lu ZR (2009). Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice. Mol Pharm, 6(3), 738-46.
  36. Soffietti R, Akerley W, Jensen RL, Bischoff J, Regierer AC (2009). The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors. Semin Oncol, 36(4 Suppl 2), S55-68.
  37. Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T (2009). Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol, 27(28), 4733-40.

Review

  1. Ragel BT, Jensen RL (2010). Aberrant signaling pathways in meningiomas. [Review]. J Neurooncol, 99(3), 315-24.
  2. Zlotnick D, Kalkanis SN, Quinones-Hinojosa A, Chung K, Linskey ME, Jensen RL, DeMonte F, Barker FG, Racine CA, Berger MS, Black PM, Cusimano M, Sekhar LN, Parsa A, Aghi M, McDermott MW (2010). FACT-MNG: tumor site specific web-based outcome instrument for meningioma patients. [Review]. J Neurooncol, 99(3), 423-31.
  3. Jensen RL (2009). Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. [Review]. Journal of Neuro-Oncology, 92(3), 317-35.

Case Report

  1. Mumert ML, Jensen EM, Jensen R (2010). Parafalcine lesions in the cancer patient: diagnostic dilemma--meningioma or metastatic lesion? J Neurooncol, 99(1), 135-9.
  2. Mumert ML, Walsh M, Jensen RL (2009). Pleomorphic liposarcoma originating from intracranial dura mater. J Neurooncol, 97(1), 149-153.

Clinical Trials

Video & News

Video